ANDA 75262, held by Actavis Mid Atlantic. Albuterol Sulfate.
As of Nov 18, 2026, ANDA 75262 (Albuterol Sulfate), held by Actavis Mid Atlantic, was first approved by FDA on Mar 30, 1999, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 30, 1999 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Albuterol SulfateEQ 2MG BASE/5ML · syrup;oral | Albuterol Sulfate | Discontinued |
| Dec 13, 2001 | Supplement 1Manufacturing | Approved | None posted |
| Mar 30, 1999 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters